Prevention Guide - Safe Handling of Hazardous Drugs - Irsst
Prevention Guide - Safe Handling of Hazardous Drugs - Irsst
Prevention Guide - Safe Handling of Hazardous Drugs - Irsst
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
5. RECEIVING AND TRANSPORT<br />
5.3.2 Delivery Containers RATING: ++<br />
Ensure that the hazardous drug delivery containers from manufacturers and distributors are<br />
properly identified.<br />
RECOMMENDATIONS<br />
5.3.2.1 The Drug Purchasing Managers should ensure that:<br />
‣ the manufacturers and distributors package hazardous drugs separately from other<br />
drugs. This recommendation is generally applied in Canada by the distributors <strong>of</strong> the<br />
antineoplastic drugs used in oncology. Until regulatory consensus has been reached in<br />
Canada regarding the necessary precautions for other hazardous drugs, we feel it is not<br />
very realistic to require distributors to provide separate packaging and labeling for<br />
other drugs not used in oncology.<br />
‣ the manufacturers and distributors package antineoplastic drugs in a plastic bag placed<br />
inside a properly sealed cardboard box marked with the symbol C (cytotoxic). If this<br />
cardboard box is placed in a rigid delivery container, the container must also be<br />
marked with the symbol C (cytotoxic). The delivery container may contain other, nonhazardous<br />
drugs.<br />
‣ the distributor cleans the delivery containers regularly.<br />
For the sake <strong>of</strong> efficiency, these measures may be carried out at a regional or provincial<br />
level.<br />
<br />
ASHP, p. 1175 ♦ NIOSH, p. 12<br />
5.3.3 <strong>Handling</strong> <strong>Hazardous</strong> Drug Delivery Containers RATING: +++<br />
Ensure that hazardous drug delivery containers are unpacked in the Pharmacy<br />
Department.<br />
RECOMMENDATIONS<br />
5.3.3.1 The receiving dock workers should check the integrity <strong>of</strong> the delivery containers upon<br />
receipt; in the event <strong>of</strong> breakage or a damaged parcel likely to cause a spill, apply the Spill<br />
Protocol (Appendix 4).<br />
5.3.3.2 Delivery containers should immediately be taken by to the Pharmacy Department by the<br />
receiving dock workers or the distributor.<br />
5.3.3.3 The receiving dock or storeroom workers should not open the delivery containers. Only<br />
the Pharmacy Department workers are authorized to proceed with the unpacking and<br />
subsequent steps.<br />
5.3.3.4 The delivery containers should be handled with care to avoid breakage <strong>of</strong> the hazardous<br />
drug containers and should not be left unattended in a corridor.<br />
<br />
APES, p. 5-35 ♦ ASHP, p. 1175 ♦ OPQ, Section 6.2<br />
5-2 ASSTSAS PREVENTION GUIDE – SAFE HANDLING OF HAZARDOUS DRUGS